Blockade of metabotropic glutamate receptors inhibits cognition and neurodegeneration in an MPTP-induced Parkinson's disease rat model

► MPTP causes neurodegeneration and impairments in working memory and recognition. ► MPEP treatment reverses the above MPTP-induced deficits. ► MPEP has potential in the treatment for Parkinson's disease dementia.